There is no single correct dosage of aspirin because the right amount depends entirely on why you are taking it. For preventing a second heart attack, most evidence now points to 81 mg daily as being just as effective as 325 mg and causing less bleeding. During an actual heart attack, the recommended loading dose jumps to roughly 160 to 325 mg chewed immediately. For primary prevention in people who have never had a cardiovascular event, most current guidelines advise against routine aspirin use altogether. And for pregnancy-related uses like preeclampsia prevention, the dose and timing differ yet again. The range of legitimate aspirin dosages spans from about 75 mg to well over 1,000 mg depending on the clinical context, which is why “take an aspirin” is far less simple than it sounds.
During a Heart Attack or Acute Coronary Event
When someone is having a suspected heart attack, speed matters more than precision. The goal is to get aspirin’s antiplatelet effect working within minutes. A loading dose of 160 to 325 mg, chewed rather than swallowed whole, is standard practice. Chewing crushes the tablet and speeds absorption through the mouth’s lining and stomach, getting the drug into the bloodstream far faster than waiting for a coated pill to dissolve in the intestine. With a loading dose in this range, platelet-blocking activity kicks in within minutes.1PubMed Central. Oral Antiplatelet Therapy in Acute Coronary Syndromes: Recent Developments
There has been some debate about whether the higher or lower end of that range is better during an acute event. Data from patients treated for ST-elevation heart attacks suggest that an initial dose of 162 mg may be as effective as 325 mg and possibly safer.2PubMed. Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy In practice, this is why you often hear “chew a regular aspirin” (325 mg) or “chew two baby aspirin” (162 mg) as emergency advice. Either works in an emergency, and the priority is getting some aspirin on board immediately rather than debating the ideal milligram count.
After the acute event passes, the dose drops. Daily maintenance doses of 75 to 150 mg have been shown to be just as effective as higher doses for ongoing protection after a heart attack.3PubMed. Update on aspirin in the treatment and prevention of cardiovascular disease European practice has generally settled on 100 mg daily, while American practice historically favored 325 mg, though that gap has been narrowing as newer evidence came in.1PubMed Central. Oral Antiplatelet Therapy in Acute Coronary Syndromes: Recent Developments
The 81 mg Versus 325 mg Question for Secondary Prevention
If you have already had a heart attack, stroke, or other cardiovascular event and your doctor has you on daily aspirin to prevent the next one, the dose question has been studied head-to-head. The ADAPTABLE trial randomized over 15,000 patients with established cardiovascular disease to either 81 mg or 325 mg of aspirin daily and followed them for a median of about 26 months. The result was clear: there was no meaningful difference in rates of death, heart attacks, or strokes between the two doses.4PubMed Central. Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease This finding held across age groups, meaning older adults did not benefit from the higher dose any more than younger ones did.
Secondary analyses of the same trial looked at whether sex or race changed the picture. No difference in outcomes between 81 mg and 325 mg was found when comparing men to women.5JAMA Cardiology. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients For race, the overall interaction was not statistically significant, though one finding drew attention: among Black participants, the 81 mg group had a somewhat higher rate of cardiovascular events than the 325 mg group. The researchers cautioned that this subgroup was relatively small and the result needs further study before changing practice.6PubMed Central. Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease
Given that 81 mg matches 325 mg in effectiveness for most people and carries a lower bleeding risk profile, 81 mg has become the default recommendation for secondary prevention in the United States. Most cardiologists now start with low-dose aspirin unless a specific reason exists to go higher.
Does Body Weight Change the Ideal Dose?
You might expect that a larger person would need a bigger dose of aspirin, and some earlier analyses of primary prevention trials suggested body weight could matter. But when researchers looked at this question within the ADAPTABLE trial population, they found no difference in cardiovascular event rates or major bleeding across body mass index categories between the 81 mg and 325 mg groups.7Circulation. Abstract 16330: Aspirin Dosing by Body Mass Index: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness Interestingly, overall event rates were actually lower in people with higher BMI, an observation that echoes the so-called “obesity paradox” seen in other cardiovascular research. For now, the evidence does not support adjusting your aspirin dose based on how much you weigh.
Primary Prevention and Who Should Not Bother
This is where the aspirin dosing conversation has shifted most dramatically in recent years. For decades, millions of healthy people took a daily baby aspirin hoping to prevent a first heart attack. Several large trials over the past decade tested that idea in populations with low to moderate cardiovascular risk and found the benefits questionable. The bleeding risk, particularly gastrointestinal and intracranial bleeding, generally offset whatever modest reduction in heart attacks aspirin provided.
As a result, both American and European cardiology guidelines have pulled back. The American College of Cardiology and American Heart Association now restrict aspirin for primary prevention to select high-risk groups and advise against routine use in everyone else. European Society of Cardiology guidelines go further and generally discourage aspirin for primary prevention altogether, limiting it to very specific high-risk scenarios.8PubMed. Aspirin for Primary Prevention of Cardiovascular Disease: A Contemporary Review If you do not already have heart disease and your doctor has not specifically told you to take aspirin, current evidence suggests you probably should not be on it.
Bleeding Risks and Why Dose Matters
Aspirin’s main danger is bleeding, and the relationship between dose and bleeding risk is not subtle. In a large study of women followed over many years, those taking more than 14 aspirin tablets per week had roughly double the risk of gastrointestinal bleeding compared to non-users, even after adjusting for how long they had been taking it. The dose-response pattern held for both upper and lower GI bleeding, with upper GI bleeding risk more than tripling at high doses.9PubMed Central. Long Term Use of Aspirin and the Risk of Gastrointestinal Bleeding
Beyond the gut, aspirin raises the risk of bleeding inside the skull. A meta-analysis of eight randomized trials found that low-dose aspirin increased the risk of any intracranial bleeding by about 37% compared to placebo, translating to roughly two additional intracranial hemorrhages per 1,000 people treated. The risk appeared greatest for bleeding between the skull and brain surface, and two patient groups showed heightened vulnerability: people of Asian descent and those with low body mass index.10PubMed Central. Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease A secondary analysis of the ASPREE trial in healthy older adults confirmed this pattern, showing significantly more intracranial bleeding events in the aspirin group than placebo.11JAMA Network Open. Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People
For older adults specifically, the extended follow-up of the ASPREE trial showed a persistently higher rate of major hemorrhage in the aspirin group compared to placebo.12European Heart Journal. Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial This is a major reason why starting aspirin after age 70 purely for prevention is now generally advised against.
Protecting Your Stomach if You Need Long-Term Aspirin
If you are on daily aspirin because you have established heart disease and cannot stop, the GI bleeding risk can be managed. Proton pump inhibitors, the class of acid-suppressing drugs that includes omeprazole and pantoprazole, substantially reduce aspirin-related stomach ulcers and bleeding. A meta-analysis found that PPIs cut the odds of low-dose aspirin-associated upper GI ulcers by about 84% and bleeding by about 73% compared to controls.13PubMed Central. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries Another systematic review confirmed that PPIs substantially lowered upper GI bleeding risk compared to placebo or no treatment and outperformed older acid-reducing drugs like H2 blockers.14PubMed. Proton pump inhibitors for prevention of upper and lower gastrointestinal bleeding in patients taking aspirin: a systematic review and meta-analysis For patients on dual antiplatelet therapy (aspirin plus another blood thinner like clopidogrel), PPIs prevented GI bleeding without increasing the risk of cardiovascular events.13PubMed Central. Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries If you are taking aspirin daily and have risk factors for stomach problems, asking your doctor about a PPI is reasonable.
Enteric-Coated Versus Plain Aspirin
Many people assume enteric-coated aspirin is the smarter choice because it is designed to dissolve in the intestine rather than the stomach, theoretically sparing the stomach lining. The absorption story is more complicated than the marketing suggests. Enteric coating delays absorption significantly and can result in lower and less predictable blood levels of aspirin. In patients with type 2 diabetes, enteric-coated aspirin produced significantly lower plasma levels and a weaker ability to block platelet activity compared to the same dose of plain aspirin. The time needed to reach near-complete platelet inhibition was roughly 48 hours for enteric-coated aspirin versus about 17 hours for plain aspirin at the same 325 mg dose.15Cor et Vasa. Enteric-coated aspirin in cardiac patients: Is it less effective than plain aspirin? This delayed and reduced absorption has been called “aspirin pseudoresistance,” where the drug appears not to be working when the real problem is that it is not getting absorbed properly.
That said, the picture is not entirely one-sided. At least one study in healthy volunteers found that 100 mg of enteric-coated and plain aspirin were equally effective at inhibiting platelet aggregation and thromboxane production.16PubMed. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects The discrepancy might come down to dose and the patient population: absorption issues with enteric coating may become more clinically meaningful at higher doses or in people with diabetes and other conditions that slow gut motility. If you are taking low-dose aspirin and your platelet tests show good response, the coating probably does not matter much. But if there is ever a question about whether your aspirin is “working,” switching to plain aspirin is a simple first step before exploring other explanations.
The Ibuprofen Problem
One of the most underappreciated issues with aspirin dosing involves a common over-the-counter painkiller: ibuprofen. Aspirin works by permanently disabling an enzyme on platelets, but it needs access to that enzyme’s binding site. Ibuprofen temporarily blocks the same site. If you take ibuprofen before your aspirin, the ibuprofen sits in the binding pocket and prevents aspirin from doing its job. Modeling data suggest that ibuprofen taken up to 12 hours before aspirin can completely cancel aspirin’s antiplatelet effect.17PubMed. Prediction of time-dependent interaction of aspirin with ibuprofen using a pharmacokinetic/pharmacodynamic model
Taking ibuprofen more than two hours after aspirin appears to avoid the interaction, because aspirin has already had time to permanently disable the enzyme before ibuprofen shows up. Acetaminophen (Tylenol) and certain other anti-inflammatory drugs like diclofenac do not cause this problem.18PubMed. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin If you rely on aspirin for heart protection and need a painkiller, acetaminophen is the safest bet. If you must use ibuprofen, take your aspirin first and wait at least two hours before taking ibuprofen.
Aspirin in Pregnancy for Preeclampsia Prevention
Low-dose aspirin has a separate role entirely in pregnancy, where it is used to reduce the risk of preeclampsia in women identified as high-risk. The doses studied range from 60 mg to 150 mg daily, usually started between 12 and 16 weeks of gestation.19PubMed Central. Preventing Preeclampsia With Low-Dose Aspirin: A Systematic Review of Efficacy Across Diverse Populations Standard American practice has typically recommended 81 mg daily, but there is growing evidence that the higher end of the dose range works better. A meta-analysis comparing 75 to 81 mg versus 150 to 162 mg found that the higher dose reduced preterm preeclampsia significantly more, cutting the risk by about two-thirds compared to the lower dose.20PubMed. Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis
However, not all trials have been positive. A large trial of 60 mg daily aspirin in over 2,500 high-risk pregnant women found no significant reduction in preeclampsia compared to placebo, and no improvement in perinatal outcomes.21PubMed. Low-dose aspirin to prevent preeclampsia in women at high risk The difference may come down to dose and timing: 60 mg appears to be at the low end of what is effective, and starting later in pregnancy seems to diminish the benefit. The trend in obstetric practice is moving toward higher doses in the 150 mg range, started before 16 weeks of gestation.
Children, Kawasaki Disease, and Reye Syndrome
Aspirin use in children is mostly off-limits because of Reye syndrome, a rare but often fatal condition involving severe brain and liver damage. Reye syndrome typically follows a viral illness and has been strongly linked to aspirin use in children. Death occurs in about 30 to 40% of cases.22PubMed. Aspirin and Reye syndrome: a review of the evidence Since public health warnings about this link began in the 1980s, Reye syndrome has become extremely rare, precisely because parents stopped giving children aspirin for fevers.
The one major exception is Kawasaki disease, an inflammatory condition affecting blood vessels in young children. Aspirin has traditionally been used at high doses during the acute phase. However, a systematic review and meta-analysis found that low-dose aspirin worked as well as high-dose aspirin for the outcomes that matter most, including the development of coronary artery aneurysms, the duration of fever, and the length of hospital stays.23PubMed Central. The Effectiveness of No or Low-Dose versus High-Dose Aspirin in Treating Acute Kawasaki Disease: A Systematic Review and Meta-Analysis This has prompted many pediatric centers to move toward lower aspirin doses for Kawasaki disease.
Aspirin and Colorectal Cancer Risk
Beyond heart disease, aspirin has attracted attention for its potential to reduce colorectal cancer risk. The evidence here involves very long time horizons. Observational studies and trial data suggest that aspirin taken daily at doses between 75 and 325 mg for years can meaningfully lower both the incidence and mortality of colorectal cancer. One pooled analysis of trial data found that treatment for five or more years reduced colorectal cancer incidence by roughly 37% and colorectal cancer deaths by about half.24PubMed Central. Aspirin for the prevention of colorectal cancer
A critical nuance emerged from studies of older adults: the cancer-protective benefit of aspirin used after age 70 appeared only in people who had already been taking it regularly for at least five years before turning 70. People who started aspirin at or after age 70 without prior use showed no reduction in colorectal cancer risk.25JAMA Oncology. Aspirin Use and Risk of Colorectal Cancer Among Older Adults This suggests that aspirin’s cancer-prevention effect builds slowly and that starting late in life specifically for this purpose is unlikely to help.
When You Stop Taking Aspirin
If you have been on aspirin for cardiovascular protection, stopping abruptly carries its own risks. When aspirin is withdrawn, there can be a rebound increase in platelet stickiness and clotting activity. The surgical stress of an operation compounds this by creating its own prothrombotic state. A meta-analysis found that stopping aspirin was associated with a significantly increased risk of heart attack and death. In one randomized trial comparing aspirin continuation versus discontinuation around surgery, stopping aspirin led to a statistically significant increase in major adverse cardiovascular events within 30 days.26British Journal of Anaesthesia. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial This does not mean aspirin should never be stopped before surgery, but the decision requires weighing bleeding risk against cardiovascular risk, and it should always be made with your surgeon and cardiologist rather than on your own.
Morning Versus Bedtime Dosing
Some earlier, widely publicized research suggested that taking aspirin at bedtime rather than in the morning could lower blood pressure. A randomized crossover trial tested this directly in cardiovascular patients taking low-dose aspirin and found no blood pressure difference between bedtime and morning dosing. Bedtime aspirin did reduce morning platelet reactivity compared to morning dosing, which makes pharmacological sense since platelet activity and heart attack risk both peak in the early morning hours.27Hypertension. Time-dependent effects of aspirin on blood pressure and morning platelet reactivity: a randomized cross-over trial Whether that small improvement in morning platelet suppression translates to fewer actual heart attacks has not been proven. Most doctors will tell you that taking aspirin consistently at any time of day matters more than obsessing over the clock.